In order to improve speed to therapy, we must never stop measuring it. In addition to devoting resources to decreasing time to first fill/dose, manufacturers and their vendor partners should recognize the critical role that each stakeholder plays in a patient’s entire therapy journey. By prioritizing education and communication strategies, manufacturers reduce barriers, increase access, and improve adherence. The result: continuity of care and faster access to therapy.
Traditional prescription adherence measures have been around for two to three decades. These programs’ ability to drive patient compliance are well understood – both in their effectiveness and their limitations.